Super Bowl Ad for Compounded Weight Loss Drugs Draws Criticism Over Safety and Regulation

Hims & Hers' commercial highlights affordability but faces scrutiny for promoting non-FDA-approved medications during a high-profile event.

Hims & Hers aired a Super Bowl ad promoting compounded weight loss drugs as affordable alternatives to branded medications like Ozempic and Wegovy.
Critics, including pharmaceutical industry groups and experts, argue the ad is misleading, as compounded drugs are not FDA-approved and carry potential safety risks.
Compounded medications, which are often cheaper, are typically allowed only during drug shortages and may lack the safety assurances of branded products.
The ad has raised concerns about regulatory oversight, with experts warning that compounded drugs can lead to dosing errors or involve unregulated suppliers.
Hims & Hers claims its ingredients are sourced from FDA-regulated manufacturers, but the ad's lack of explicit risk disclosures has drawn backlash from health advocacy groups.